Symptomatic Myocarditis Post COVID-19 Vaccination

There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Palak, Desai, Dhaval, Ganta, Nagapratap, Tadepalli, Satish, Kata, Priyaranjan, Kanukuntla, Anish, Schoenfeld, Matthew, Sathya, Bharath, Okere, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095512/
https://www.ncbi.nlm.nih.gov/pubmed/35573513
http://dx.doi.org/10.7759/cureus.24052
Descripción
Sumario:There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, primarily after the second dose of messenger RNA (mRNA) COVID-19 vaccines. We present a case series of myopericarditis post mRNA (Moderna) and myocarditis post vector-based (Johnson & Johnson) COVID-19 vaccines. We intend to highlight the importance of early diagnosis and treatment of vaccine-related myocarditis to reduce mortality and morbidity. 

Ejemplares similares